From earlier epidemiologic findings of AMD studies (the Blue Mountains Eye study5, Beaver Dam Eye Study6, and the US NHANES III7), and more recent investigation of genetic polymorphisms in complement factor H (CFH)8–11, emerging evidence has suggested an association between renal impairment and AMD (Supplementary Table S1). The gene discussed is CFH; the disease is age-related macular degeneration.